Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Heston

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
The Urologic Clinics of North America|February 1, 1991
Future developments of nonhormonal systemic therapy for prostatic carcinomaJ A Warner, W D Heston
Cancer Research|June 1, 1989
Effect of coumarin on the normal rat prostate and on the R-3327H prostatic adenocarcinomaB Omarbasha, W R Fair, W D Heston
Cancer Letters|July 1, 1981
Effect of high dose diethylstilbestrol and ICRF-159 on the growth and metastases of the R3327 MAT-LyLu prostate-derived tumorW D Heston, D Kadmon, W R Fair
Journal of Neurochemistry|October 1, 1972
Purification and characterization of an NADH-linked aldehyde reductase from bovine brainV G Erwin, W D Heston, B Tabakoff
Cancer Letters|May 1, 1982
Growth inhibition of a prostate tumor by alpha-difluoromethylornithine and by cyclophosphamideW D Heston, D Kadmon, W R Fair
The Journal of Urology|December 1, 1983
Renal cell carcinoma and the clonogenic assayJ Fleischmann, W D Heston, W R Fair
The Prostate|January 1, 1981
Effect of surgery and adjuvant chemotherapy on the R3327 MAT-Ly Lu tumorD Kadmon, W D Heston, W R Fair
The Journal of Urology|June 1, 1982
Treatment of a metastatic prostate derived tumor with surgery and chemotherapyD Kadmon, W D Heston, W R Fair
Progress in Clinical and Biological Research|January 1, 1987
Mitogenic activity of prostatic extractsW D Heston, M A Bulbul, W R Fair
Current Opinion in Urology|December 1, 1999
Monoclonal antibodies: will they become an integral part of the evaluation and treatment of prostate cancer--focus on prostate-specific membrane antigen?S S Chang, N H Bander, W D Heston
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
The Urologic Clinics of North America|February 1, 1991
Future developments of nonhormonal systemic therapy for prostatic carcinomaJ A Warner, W D Heston
Cancer Research|June 1, 1989
Effect of coumarin on the normal rat prostate and on the R-3327H prostatic adenocarcinomaB Omarbasha, W R Fair, W D Heston
Cancer Letters|July 1, 1981
Effect of high dose diethylstilbestrol and ICRF-159 on the growth and metastases of the R3327 MAT-LyLu prostate-derived tumorW D Heston, D Kadmon, W R Fair
Journal of Neurochemistry|October 1, 1972
Purification and characterization of an NADH-linked aldehyde reductase from bovine brainV G Erwin, W D Heston, B Tabakoff
Cancer Letters|May 1, 1982
Growth inhibition of a prostate tumor by alpha-difluoromethylornithine and by cyclophosphamideW D Heston, D Kadmon, W R Fair
The Journal of Urology|December 1, 1983
Renal cell carcinoma and the clonogenic assayJ Fleischmann, W D Heston, W R Fair
The Prostate|January 1, 1981
Effect of surgery and adjuvant chemotherapy on the R3327 MAT-Ly Lu tumorD Kadmon, W D Heston, W R Fair
The Journal of Urology|June 1, 1982
Treatment of a metastatic prostate derived tumor with surgery and chemotherapyD Kadmon, W D Heston, W R Fair
Progress in Clinical and Biological Research|January 1, 1987
Mitogenic activity of prostatic extractsW D Heston, M A Bulbul, W R Fair
Current Opinion in Urology|December 1, 1999
Monoclonal antibodies: will they become an integral part of the evaluation and treatment of prostate cancer--focus on prostate-specific membrane antigen?S S Chang, N H Bander, W D Heston
Pageof 12